Page last updated: 2024-10-30

lomustine and Hyperpigmentation

lomustine has been researched along with Hyperpigmentation in 1 studies

Hyperpigmentation: Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.

Research Excerpts

ExcerptRelevanceReference
"We describe 5 cases of chemotherapy-related reticulate hyperpigmentation in patients treated with different chemotherapeutic regimens, in particular paclitaxel or cytarabine."4.91Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature. ( Boulinguez, S; Gadaud, N; Gladieff, L; Guenounou, S; Lamant, L; Masson Regnault, M; Recher, C; Roche, H; Sibaud, V; Tournier, E, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masson Regnault, M1
Gadaud, N1
Boulinguez, S1
Tournier, E1
Lamant, L1
Gladieff, L1
Roche, H1
Guenounou, S1
Recher, C1
Sibaud, V1

Reviews

1 review available for lomustine and Hyperpigmentation

ArticleYear
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
    Dermatology (Basel, Switzerland), 2015, Volume: 231, Issue:4

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosp

2015